Risk prediction models for imported infectious diseases: A systematic review
Shuaiming Xu1, Jialong Xie1, Linshen Xie2
1West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Predictive models for imported infectious diseases show significant heterogeneity and poor reporting of performance. Enhancing transparency and external validation is crucial for effective global public health decision-making.
Area of Science:
- Epidemiology
- Public Health
- Mathematical Modeling
Background:
- Accurate prediction models for imported infectious diseases are vital for global health security, including early warning and resource allocation.
- Existing models for imported infectious diseases exhibit substantial heterogeneity in structure, reporting, and performance, hindering practical application.
Purpose of the Study:
- To systematically review and analyze the landscape of predictive models for imported infectious diseases.
- To identify commonalities, variations, and limitations in current modeling approaches, focusing on predictors, performance metrics, and validation strategies.
Main Methods:
- Conducted a systematic review following PRISMA guidelines, searching PubMed, Scopus, and Embase.
- Extracted data from 273 studies (308 models) using the CHARMS framework, focusing on model characteristics and validation.
- Categorized models by transmission route (respiratory, vector-borne, fecal-oral) and modeling approach (dynamic, statistical, machine learning).
Main Results:
- Most models focused on respiratory or vector-borne diseases, primarily in airport settings, estimating disease burden.
- Limited reporting of predictive performance (54.6%) and validation (38.5% internal, 9.9% external) was observed.
- Predictors varied by transmission route, with environmental factors for vector-borne and mobility for respiratory/fecal-oral diseases.
Conclusions:
- Imported infectious disease models are constrained by limited scenario diversity and inadequate reporting of performance and validation.
- Future models require improved transparency, broader cross-border context consideration, and robust external validation.
- Enhanced modeling is essential to improve utility in global public health decision-making.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:08Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
Related Concept Videos
Steps in Outbreak Investigation
Infectious Diseases and Their Occurrence
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Principles of Disease Surveillance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
